Breaking News Instant updates and real-time market news.

DBVT

DBV Technologies

$22.45

-0.57 (-2.48%)

05:12
02/27/18
02/27
05:12
02/27/18
05:12

DBV milk allergy data positive, but questions remain, says Deutsche Bank

Last night's positive Phase II data for Viaskin Milk in patients with allergy to cow's milk protein supports the Viaskin platform, but focus remains on DBV Technologies' regulatory process for peanut allergy, Deutsche Bank analyst Andrew Peters says in a research note. The analyst thinks the Miles data are potentially supportive of the overall platform as well as also represent an additional opportunity for the company. He notes that although benefits were observed for children ages 2-11, the treatment did not show a meaningful effect in adolescents, which is similar to the results with Viaskin Peanut. This is potentially indicative of some challenges to the applicability of Viaksin in older patients or indicating the need for further fine-tuning of dose and patch, Peters writes. He reiterates a Buy rating on DBV Technologies with a $30 price target. The analyst believes Viaskin Peanut provides an "attractive risk/benefit" to peanut allergy patients and that the implied risk at current share levels is "overly cautious."

DBVT DBV Technologies
$22.45

-0.57 (-2.48%)

02/16/18
02/16/18
UPGRADE

DBV Technologies upgraded to Buy from Hold at Portzamparc
Portzamparc Societe de Bourse analyst Christophe Dombu upgraded DBV Technologies to Buy.
02/20/18
JEFF
02/20/18
NO CHANGE
Target $37
JEFF
Buy
DBV Technologies wins over Aimmune on safety, says Jefferies
Jefferies analyst Eun Yang says that as expected, Aimmune Therapeutics (AIMT) reported "strong" Phase 3 efficacy data for AR101 in peanut allergy. While the Phase 3 designs are different, on efficacy, AR101 is superior to DBV Technologies' (DBVT) Viaskin Peanut (VP), Yang tells investors in a research note. She believes, however, that Viaskin Peanut "wins on safety" and would be a preferred option for children. The analyst expects both products to win FDA approval in the first half of 2019. Yang keeps a Buy rating on DBV shares with a $37 price target. The stock in late morning trading is down 69c to $25.17 while Aimmune is down 6.5% to $34.78.
02/20/18
DBAB
02/20/18
NO CHANGE
Target $30
DBAB
Buy
Deutsche sees room for multiple players in peanut allergy space
Aimmune Therapeutics' (AIMT) top-line results from the Palisade study suggest that AR101 could be an effective treatment for the desensitization of peanut allergy patients to peanut protein, Deutsche Bank analyst Andrew Peters tells investors in a research note. The analyst, however, believes AR101 "continues to be a potentially challenging therapy from a tolerability and safety perspective" with 20.4% of patients discontinuing therapy for all causes. AR101's profile is "far from suggestive of an all-encompassing option for patients," leaving "meaningful opportunity" for other agents, Peters contends. As such, he sees room for both AR101 and DBV Technologies' (DBVT) Viaskin Peanut. The analyst keeps a Buy rating on DBV shares with a $30 price target.
02/26/18
02/26/18
NO CHANGE
Target $37

Buy
DBV Phase II milk data 'highly encouraging,' says Jefferies
Phase II data for DBV Technologies' Viaskin Milk shows significant response in a subgroup of kids with Milk allergy, Jefferies analyst Eun Yang tells investors in a research note. This is "highly encouraging" given the high natural resolution of milk allergy in kids and high placebo rates, Yang contends. She believes Viaskin continues to show safety and high compliance and estimates Viaskin Milk is worth $18 per share if successful in Phase III, versus $3 per share currently. The analyst keeps a Buy rating on DBV Technologies with a $37 price target.

TODAY'S FREE FLY STORIES

WIT

Wipro

$5.23

0.07 (1.36%)

09:58
07/20/18
07/20
09:58
07/20/18
09:58
Earnings
Wipro reports Q1 EPS 7c, consensus 7c »

Wipro reports Q1 gross…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

HON

Honeywell

$151.70

4.13 (2.80%)

09:56
07/20/18
07/20
09:56
07/20/18
09:56
Hot Stocks
Honeywell says proactively managing direct, indirect impacts from tariffs »

Says sales growth was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

MGM

MGM Resorts

$30.64

-0.19 (-0.62%)

09:55
07/20/18
07/20
09:55
07/20/18
09:55
Hot Stocks
MGM Resorts says 'well-positioned' in Japan »

MGM Resorts International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

BHLB

Berkshire Hills Bancorp

$40.90

-0.05 (-0.12%)

09:55
07/20/18
07/20
09:55
07/20/18
09:55
Downgrade
Berkshire Hills Bancorp rating change  »

Berkshire Hills…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTAS

Cintas

$202.71

8.92 (4.60%)

, STI

SunTrust

$71.16

2.16 (3.13%)

09:55
07/20/18
07/20
09:55
07/20/18
09:55
Options
Early notable gainers among liquid option names on July 20th »

Notable gainers among…

CTAS

Cintas

$202.71

8.92 (4.60%)

STI

SunTrust

$71.16

2.16 (3.13%)

COF

Capital One

$98.50

3.18 (3.34%)

VFC

VF Corp.

$91.37

2.16 (2.42%)

SWK

Stanley Black & Decker

$144.21

4.61 (3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

CTXS

Citrix

$108.80

-0.86 (-0.78%)

09:54
07/20/18
07/20
09:54
07/20/18
09:54
Downgrade
Citrix rating change  »

Citrix cut to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 08

    Aug

09:45
07/20/18
07/20
09:45
07/20/18
09:45
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

CVLT

Commvault

$69.20

(0.00%)

09:44
07/20/18
07/20
09:44
07/20/18
09:44
Hot Stocks
Commvault appoints two new directors following agreement with Elliott »

Commvault last night…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 08

    Aug

FB

Facebook

$208.08

(0.00%)

, GOOGL

Alphabet Class A

$1,199.26

(0.00%)

09:43
07/20/18
07/20
09:43
07/20/18
09:43
Recommendations
Facebook, Alphabet Class A analyst commentary  »

Facebook expected Q2…

FB

Facebook

$208.08

(0.00%)

GOOGL

Alphabet Class A

$1,199.26

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 25

    Jul

  • 18

    Sep

HON

Honeywell

$147.57

(0.00%)

, SWKS

Skyworks

$102.46

(0.00%)

09:40
07/20/18
07/20
09:40
07/20/18
09:40
Options
Unusually active option classes on open July 20th »

Unusual total active…

HON

Honeywell

$147.57

(0.00%)

SWKS

Skyworks

$102.46

(0.00%)

EWZ

MSCI Brazil Index

$34.46

(0.00%)

GE

General Electric

$13.73

(0.00%)

NUGT

Direxion Gold Miners Bull

$22.20

(0.00%)

JD

JD.com

$36.87

(0.00%)

SLV

iShares Silver Trust

$14.41

(0.00%)

XLI

Industrial Select Sector SPDR

$74.53

(0.00%)

IBM

IBM

$149.25

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 20

    Jul

  • 06

    Aug

  • 14

    Aug

  • 04

    Sep

09:38
07/20/18
07/20
09:38
07/20/18
09:38
General news
Trump trade and rate comments lead to mixed open »

Stock futures fell…

AMZN

Amazon.com

$1,812.85

-29.51 (-1.60%)

09:34
07/20/18
07/20
09:34
07/20/18
09:34
Recommendations
Amazon.com analyst commentary  »

Amazon's AWS to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 16

    Aug

SAUC

Diversified Restaurant

$1.22

0.05 (4.27%)

09:33
07/20/18
07/20
09:33
07/20/18
09:33
Syndicate
Diversified Restaurant 6M share Secondary priced at $1.00 »

Dougherty acted as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLMD

Galmed

$14.99

0.96 (6.84%)

09:31
07/20/18
07/20
09:31
07/20/18
09:31
Initiation
Galmed initiated  »

Galmed initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISRG

Intuitive Surgical

$521.30

-6.37 (-1.21%)

09:31
07/20/18
07/20
09:31
07/20/18
09:31
Recommendations
Intuitive Surgical analyst commentary  »

Intuitive Surgical price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 27

    Aug

BBD

Banco Bradesco

$7.61

0.04 (0.53%)

09:30
07/20/18
07/20
09:30
07/20/18
09:30
Upgrade
Banco Bradesco rating change  »

Banco Bradesco upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$13.73

-0.02 (-0.15%)

09:30
07/20/18
07/20
09:30
07/20/18
09:30
Hot Stocks
Breaking Hot Stocks news story on General Electric »

General Electric says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

09:30
07/20/18
07/20
09:30
07/20/18
09:30
General news
Fed funds futures are modestly lower »

Fed funds futures are…

PM

Philip Morris

$80.90

-1.26 (-1.53%)

09:28
07/20/18
07/20
09:28
07/20/18
09:28
Downgrade
Philip Morris rating change  »

Philip Morris downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$43.43

0.09 (0.21%)

09:27
07/20/18
07/20
09:27
07/20/18
09:27
Recommendations
Twitter analyst commentary  »

Twitter Q2 consensus may…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

PPG

PPG

$106.35

-0.49 (-0.46%)

09:25
07/20/18
07/20
09:25
07/20/18
09:25
Hot Stocks
PPG announces general counsel Glenn Bost to retire, Anne Foulkes to succeed »

PPG announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:25
07/20/18
07/20
09:25
07/20/18
09:25
General news
U.S. Data Slate - Week of July 23: »

U.S. Data Slate - Week of…

ESRX

Express Scripts

$76.73

-1.17 (-1.50%)

, ABC

AmerisourceBergen

$85.58

-0.76 (-0.88%)

09:24
07/20/18
07/20
09:24
07/20/18
09:24
Downgrade
Express Scripts, AmerisourceBergen, McKesson rating change  »

Express Scripts,…

ESRX

Express Scripts

$76.73

-1.17 (-1.50%)

ABC

AmerisourceBergen

$85.58

-0.76 (-0.88%)

MCK

McKesson

$133.80

-0.57 (-0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 02

    Aug

CRBP

Corbus Pharmaceuticals

$5.50

0.25 (4.76%)

09:23
07/20/18
07/20
09:23
07/20/18
09:23
Hot Stocks
Corbus Pharmaceuticals receives FDA orphan drug designation for lenabasum »

Corbus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$68.97

-0.89 (-1.27%)

09:22
07/20/18
07/20
09:22
07/20/18
09:22
Hot Stocks
Citi raises quarterly dividend to 45c from 32c »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

  • 15

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.